Lilly competitor fails to win FDA backing for diabetes treatment
AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.
Health Care & Insurance
Articles
Administration slashes enrollment goals for Obamacare
Health and Human Services Secretary Sylvia M. Burwell set a target of 10 million people enrolled and paying their premiums by the end of next year—about half the enrollment that was originally predicted.
Pence awards $3.5M contract to anti-abortion charity group
Gov. Mike Pence cited the successes of a $1 million pilot program as reason for granting a new $3.5 million contract to Real Alternatives, a Pennsylvania-based charity.
Indiana Blood Center names new chief executive
Long-time health care executive Charles C. Miraglia was picked by the center’s board of directors to replace interim CEO Dan A. Waxman, who has been in that position since January.
Cook executive, daughter die in plane crash
William S. Gibbons Jr., Cook's vice president of of global engineering, and his 15-year-old daughter, Abbey, were killed when the plane crashed into Buffalo Mountain in eastern Tennessee.
UPDATE: Lilly halts work on potential blockbuster cholesterol drug
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
Lilly expands China drug partnership in growing cancer market
Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.
Spiking drug prices punch holes in health insurers’ finances
Spending on prescription drugs has soared 451 percent this year at Indianapolis-based MDwise as new drugs for hepatitis C and cancer soar above $100,000 per patient.
Lilly to add 50 employees at R&D center in New York
The drugmaker is trying to beef up its work on using the immune system to fight cancer. Indianapolis will remain Lilly’s main hub for research and development.
Go figure: As patients’ anger over costs spikes, health care prices barely budge
Patients’ anger over high deductibles and high drug prices is spurring presidential candidates to respond—even as the actual prices of health care services are growing slower than at any time since 1990.
Hospital CEO: Telehealth could dampen future health care construction
Bryan Mills, CEO of the Community Health Network hospital system, said a recent pickup in health care construction could slow down if providers can successfully care for patients remotely via the Internet and phones.
American Senior fires No. 2 executive in wake of FBI raid
American Senior Communities has fired its chief operating officer and accepted the resignation of its chief financial officer—17 days after an FBI raid of its offices and the home of its former CEO James Burkhart.
The Anthem-Cigna Marriage: A Love Story in Three Acts
A 22-page timeline of events leading up to the $54 billion merger agreement between Anthem and Cigna shows that company executives fell in love early, but the Anthem board made them break up and they chased other lovers. But in the end, they were each other’s only choice.
Nurse-unionization efforts stall at IU Health
Five months after it expected to hold an election, the union trying to organize nurses at Indiana University Health’s downtown hospitals doesn’t even have a projected date for a vote.
IU researchers develop suicide-prediction tool
Researchers at the Indiana University School of Medicine think they have found a way to predict possible suicides using blood tests and questionnaires on tablet computers.
Butler helping to form doctor leadership program
The program will help train physicians in financial analysis, management, organizational politics, and how to manage change in an organization.
Puerto Rico plans new corporate tax to replace excise levy
Puerto Rico officials are looking to replace an expiring tax with a new levy to draw much-needed revenue from the world’s best-selling medications while seeking to avoid driving U.S. manufacturers such as Eli Lilly and Co. from the commonwealth.
IU to receive up to $46M for effort to boost patient care
The university will lead a consortium of eight institutions that will use the money to create a system of coaches embedded in medical practices.
Lilly stock climbs on positive arthritis drug test
A potential rheumatoid arthritis treatment from drugmakers Eli Lilly and Co. and Incyte Corp. fared better than another drug in late-stage testing, Lilly said Tuesday.
Wheeler Mission to merge with Bloomington relief group
Wheeler will take over the operations of Backstreet Missions Inc., which was founded in 1995. In recent years, Backstreet has provided tens of thousands of meals for clients and thousands of nights of shelter.